This page is part of the FHIR Specification (v5.0.0-ballot: FHIR R5 Ballot Preview). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4
Clinical Decision Support Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile PlanDefinition.
Generated Narrative: PlanDefinition
Resource PlanDefinition "opioidcds-10"
url: http://hl7.org/fhir/ig/opioid-cds/PlanDefinition/opioidcds-10
identifier: id: urn:oid:2.16.840.1.113883.4.642.11.3, id: cdc-opioid-guidance (OFFICIAL)
version: 0.1.0
name: cdc-opioid-10
title: CDC Opioid Prescribing Guideline Recommendation #10
type: ECA Rule (PlanDefinitionType#eca-rule)
status: draft
date: 2017-04-23
publisher: Centers for Disease Control and Prevention (CDC)
description: When prescribing opioids for chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.
- | Code | Value[x] |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Medication requested (situation) (SNOMED CT#182888003) |
* | Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus') | Chronic pain (finding) (SNOMED CT#82423001) |
jurisdiction: United States of America (unknown#US)
purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.
usage: Providers should be aware if patients are taking other prescription drugs or illicit drugs that might increase their risk of an overdose.
copyright: © CDC 2016+.
topic: Opioid Prescribing ()
author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:
relatedArtifact
type: documentation
display: CDC guideline for prescribing opioids for chronic pain
library: http://example.org/fhir/Library/opioidcds-recommendation-10
action
title: Annual Urine Screening Check
description: Patient has not had a urine screening in the past 12 months
documentation
type: documentation
Triggers
- Type Name * named-event medication-prescribe condition
kind: applicability
Expressions
- Description Language Expression * Patient has not had a urine screening in the past 12 months text/cql No Screenings in Past Year dynamicValue
path: activity.extension
Expressions
- Language Expression * text/cql Get Indicator Actions
- Description * Will perform urine screening * Not for chronic pain management. Snooze 3 months
action
title: Positive Urine Screening Check
description: Patient has a urine screening testing positive for either unprescribed opioids or illicit drugs in the past 12 months
documentation
type: documentation
condition
kind: applicability
Expressions
- Description Language Expression * Patient has a positive urine screening in the past 12 months text/cql Has Positive Screening? action
title: Unprescribed Opioids Found In Urine Screening
description: Patient has a positive urine screening in the past 12 months for opioid(s), which is not prescribed
action
title: Prescribed Opioids Not Found In Urine Screening
description: Patient has a positive urine screening in the past 12 months, which does not include prescribed opioids
action
title: Illicit Drugs Found In Urine Screening
description: Patient has a positive urine screening in the past 12 months for illicit drugs
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.